Literature DB >> 8943399

Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.

J Buckner1, W W Kwok, B Nepom, G T Nepom.   

Abstract

Intermolecular interactions between peptides and class II molecules intracellularly are likely to be influenced by different pH conditions in different endosomal compartments. We compared the pH-dependent binding of peptides to HLA-DQ alleles 3.1 and 3.2, two well-studied human class II molecules with limited structural variability but different genetic associations with autoimmune diseases. Binding of the "promiscuous" binding peptide 34P3A as well as that of several allele-specific peptides were optimal for DQ3.2 at relatively acidic pH, compared with DQ3.1, with a pH optimum for DQ3.2 at pH 5.5 and for DQ3.1 at pH 6.5. A specific polymorphism at residue 57 of the DQ molecule accounted for some, but not all, of this difference. When the intrinsic stability of the class II dimer was assessed using partially denaturing gel electrophoresis after incubation at different pH, the DQ3.2 molecule demonstrated relative instability at neutral pH compared with DQ3.1, again suggesting a preference for peptide binding at relatively acidic conditions for HLA-DQ3.2. Interestingly, this preference for binding at acidic pH was not found for a class II-associated invariant chain peptide. Intrinsic alphabeta dimer stability and the pH optima for peptide binding studied in this report are likely to be significant determinants for allelic differences in DQ binding profiles in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943399

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Immunology of IDDM.

Authors:  H Noorchashm; W Kwok; A Rabinovitch; L C Harrison
Journal:  Diabetologia       Date:  1997-10       Impact factor: 10.122

2.  The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.

Authors:  C C Chao; H K Sytwu; E L Chen; J Toma; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Assessing the binding of four Plasmodium falciparum T helper cell epitopes to HLA-DQ and induction of T-cell responses in HLA-DQ transgenic mice.

Authors:  N Pimtanothai; M Parra; A H Johnson; C S David; C Katovich Hurley
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Major histocompatibility complex-linked control of autoimmunity.

Authors:  L S Wicker
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

Review 5.  Human leukocyte Antigen-DM polymorphisms in autoimmune diseases.

Authors:  Miguel Alvaro-Benito; Eliot Morrison; Marek Wieczorek; Jana Sticht; Christian Freund
Journal:  Open Biol       Date:  2016-08       Impact factor: 6.411

6.  Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.

Authors:  W M Ridgway; H Ito; M Fassò; C Yu; C G Fathman
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.